KPWS
TEVA icon

Kestra Private Wealth Services’s Teva Pharmaceuticals TEVA Stock Holding History

Kestra Private Wealth Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
30,204
+11
+0% +$366 0.01% 885
2026
Q1 		$909K Sell
30,193
-20
-0.1% -$643 0.01% 882
2025
Q4 		$943K Sell
30,213
-600
-2% -$14.8K 0.01% 834
2025
Q3 		$622K Sell
30,813
-2,351
-7% -$41.3K 0.01% 993
2025
Q2 		$556K Sell
33,164
-434
-1% -$7K 0.01% 984
2025
Q1 		$516K Buy
33,598
+2,072
+7% +$37K 0.01% 939
2024
Q4 		$695K Buy
31,526
+21,075
+202% +$383K 0.01% 784
2024
Q3 		$188K Sell
10,451
-21,918
-68% -$384K ﹤0.01% 1278
2024
Q2 		$526K Buy
32,369
+7,013
+28% +$108K 0.01% 809
2024
Q1 		$358K Sell
25,356
-2,681
-10% -$33.8K 0.01% 940
2023
Q4 		$293K Buy
28,037
+146
+0.5% +$1.36K 0.01% 958
2023
Q3 		$284K Sell
27,891
-1,009
-3% -$9.39K 0.01% 884
2023
Q2 		$218K Buy
28,900
+2,000
+7% +$16.2K 0.01% 938
2023
Q1 		$238K Sell
26,900
-685
-2% -$6.77K 0.01% 854
2022
Q4 		$252K Buy
27,585
+5,168
+23% +$45.1K 0.01% 720
2022
Q3 		$181K Sell
22,417
-3,495
-13% -$30.9K 0.01% 798
2022
Q2 		$195K Sell
25,912
-612
-2% -$5.33K 0.01% 809
2022
Q1 		$249K Buy
26,524
+1,100
+4% +$9.18K 0.01% 806
2021
Q4 		$204K Sell
25,424
-2,646
-9% -$23.9K 0.01% 902
2021
Q3 		$273K Hold
28,070
– – 0.02% 745
2021
Q2 		$278K Buy
28,070
+4,974
+22% +$52.6K 0.02% 704
2021
Q1 		$267K Buy
23,096
+857
+4% +$9.83K 0.02% 639
2020
Q4 		$213K Buy
22,239
+3,275
+17% +$31.4K 0.02% 654
2020
Q3 		$171K Buy
+18,964
New +$201K 0.01% 615

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Kestra Private Wealth Services's TEVA Position: Q2 2026 in Review

Kestra Private Wealth Services increased its Teva Pharmaceuticals (TEVA) stake by 0.04% in Q2 2026, buying an estimated $366 and bringing the position to 30,204 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #885.

Kestra Private Wealth Services first reported a position in TEVA in Q3 2020 and has held it in 24 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Kestra Private Wealth Services held 30,204 shares of Teva Pharmaceuticals worth $1.02M as of Q2 2026.
  • Kestra Private Wealth Services bought 11 Teva Pharmaceuticals shares in Q2 2026, an estimated $366.
  • Teva Pharmaceuticals made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #885 holding.
  • Kestra Private Wealth Services first reported a position in Teva Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.